Manuscripts
Abstracts
December 10, 2022
Racial disparities in newly diagnosed hematological malignancies in the United States during the COVID-19 pandemic, January 2020 to March 2021
ASH Annual Meeting & Exposition 2022
Bhandari S et al
December 6, 2022
Real world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer
San Antonio Breast Conference Symposium 2022
Sukumar JS et al
September 10, 2022
Demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with stages I-III resected NSCLC without known EGFR mutations
European Society for Medical Oncology 2022
Altorki NK et al
August 7, 2022
Long term survival outcomes in NSCLC patients with targeted therapy and immunotherapy: An IASLC analysis of ASCO CancerLinQ Discovery data
World Conference on Lung Cancer 2022
Behera M et al
June 3, 2022
Natural language processing-optimized case selection for real world evidence studies
ASCO Annual Meeting 2022
Koskimaki J et al
June 3, 2022
Associations between biomarker testing and characteristics of patients with metastatic non-small cell lung cancer (mNSCLC): an analysis of CancerLinQ Discovery (CLQD) data
ASCO Annual Meeting 2022
Mileham KF et al
June 3, 2022
Molecular testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data
ASCO Annual Meeting 2022
Behera M et al
June 3, 2022
The survival benefit of anti-HER2 treatment in the management of small (T1mic, T1a, T1b, T1c), node-negative HER2+ breast cancer
ASCO Annual Meeting 2022
Johnson K et al
June 3, 2022
Diagnosed with advanced prostate cancer: A population-based cohort from national oncology practices
ASCO Annual Meeting 2022
Kim SP et al
